Thyroid Eye Disease — Pathophysiology & Clinical Features

Overview: Epidemiology & Graves' Association

Thyroid eye disease (TED), also called Graves' orbitopathy or thyroid-associated orbitopathy, is the most common cause of both unilateral and bilateral proptosis in adults. Women are affected roughly four times as often as men, consistent with the broader female predominance of autoimmune thyroid disease generally. Men who do develop TED, however, tend to have more severe disease.

TED occurs most often in patients with Graves' disease-related hyperthyroidism, since both conditions share the same underlying autoimmune trigger. It can also arise, less commonly, in patients who are euthyroid or even hypothyroid, as in Hashimoto thyroiditis, at the time of presentation. That pattern is a reminder that TED is fundamentally an orbital autoimmune process rather than a direct consequence of circulating thyroid hormone levels. The eye disease and the thyroid gland disease can run on separate timelines: TED can precede, coincide with, or follow the diagnosis and treatment of the systemic thyroid condition.

Pathogenesis: TSH Receptor Antibodies

The autoantibody most strongly implicated in TED is the TSH receptor antibody (TRAb), also called thyroid-stimulating immunoglobulin (TSI): the same antibody class responsible for driving hyperthyroidism in Graves' disease. TSH receptors are not confined to the thyroid gland, though. Orbital fibroblasts express them too, and when TRAb binds these orbital receptors it stimulates the fibroblasts to proliferate, deposit glycosaminoglycans (hydrophilic molecules that draw in water and cause tissue edema), and differentiate into adipocytes. That sequence drives both the muscle enlargement and the orbital fat expansion seen in TED, and explains why an antibody raised against a thyroid-specific target ends up producing disease squarely in the orbit.

This glycosaminoglycan deposition and lymphocytic infiltration characteristically produce fusiform enlargement of the extraocular muscle bellies with sparing of the tendinous insertions, a pattern visible on both CT and MRI. This tendon-sparing signature is one of the more useful radiographic distinctions in orbital disease: idiopathic orbital inflammation (orbital pseudotumor) and its orbital myositis subtype, by contrast, frequently involve the tendon insertions as well. A scan showing muscle belly swelling that stops short of the tendon points specifically toward TED.

Risk Factors

Cigarette smoking is the single most significant modifiable risk factor for TED. It increases both the likelihood of developing the disease and the severity of disease once present, likely through direct effects on orbital fibroblast activation and immune signaling. Smoking cessation counseling is therefore a genuine part of TED management, not an incidental health recommendation, and it carries particular weight before radioiodine treatment of the underlying Graves' disease, which can itself transiently worsen orbital inflammation.

Clinical Features

Eyelid Signs

TED produces several classic, eponymous eyelid findings. Each is worth knowing individually, since they are commonly tested and clinically distinct from one another:

• Dalrymple sign: static upper eyelid retraction visible in primary gaze, exposing sclera above the superior limbus. This results from sympathetic overstimulation and fibrotic contracture of Müller's muscle and the levator complex.
• von Graefe sign: lag of the upper eyelid behind the globe specifically during downgaze, due to restricted relaxation of the fibrotic levator/Müller's muscle complex as the eye moves down. This is distinct from Dalrymple sign, which is a static, primary-gaze finding.
• Kocher sign: a staring appearance on upgaze.

Lid retraction, upper or lower, is one of the most common and earliest signs of TED. It is often present before significant proptosis develops.

Extraocular Muscle Involvement

The inferior rectus is the most frequently involved and enlarged extraocular muscle in TED, followed in frequency by the medial rectus. The order is commonly remembered with the mnemonic "IMSLO": inferior, medial, superior, lateral, oblique. Restrictive enlargement of the inferior rectus produces a restrictive hypotropia with limited elevation of the globe. The eye is mechanically tethered downward, which is a different problem from true weakness of the elevating muscles, and the distinction is confirmed at the bedside with a positive forced duction test: passive rotation of the globe meets resistance, indicating the limitation is mechanical (fibrotic muscle) rather than neurogenic (a nerve palsy) or myasthenic (fatigable weakness).

Classification & Activity Scoring

Two separate scoring systems are used in TED, and keeping their purposes distinct matters: one grades overall disease severity; the other grades current inflammatory activity.

The NOSPECS classification grades severity across a set of categories: No signs, Only signs (lid retraction/lag without other findings), Soft tissue involvement, Proptosis, Extraocular muscle involvement, Corneal involvement, and Sight loss from compressive optic neuropathy. Together these give a structured snapshot of how much anatomic damage TED has caused.

The Clinical Activity Score (CAS), by contrast, is a 7-point score based on signs of active inflammation, namely pain, redness, and swelling of the orbital and periorbital tissues. It answers a different question: is the disease active right now, and therefore likely to respond to immunosuppressive treatment? A CAS of 3 or more out of 7 indicates clinically active disease. The distinction matters because a patient can have high NOSPECS severity (established proptosis, muscle enlargement) alongside a low CAS, meaning burnt-out, fibrotic, inactive disease. Immunosuppression targets active inflammation; it does nothing to reverse tissue that has already fibrosed, which is why treatment selection in TED hinges on CAS rather than on severity alone.

High-Yield Pearls

• TED is the most common cause of both unilateral and bilateral adult proptosis; keep it near the top of the differential for a bulging eye.
• TRAb/TSI antibodies act on orbital fibroblast TSH receptors directly, so the eye disease can be active independent of thyroid hormone status.
• Dalrymple (static retraction) vs. von Graefe (lag on downgaze): different eponyms, different gaze positions.
• CAS ≥ 3/7 = active disease, most likely to respond to immunosuppression; NOSPECS grades cumulative severity/damage.
• Smoking cessation is a genuine, evidence-based part of TED management.

Related Topics

Continue exploring Oculoplastics & Orbit: